Research programme: neuronal nicotinic receptor modulators - Abbvie
Alternative Names: NS-1738; NSD-683; NSD-686Latest Information Update: 22 Jan 2013
At a glance
- Originator NeuroSearch
- Developer Abbott Laboratories
- Class
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists; Nicotinic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders